Arboretum Ventures is a healthcare venture capital firm based in the Midwest, dedicated to improving patient outcomes and reducing healthcare costs. With over $1 billion under management across six funds, the firm has invested in 76 portfolio companies over 20 years, with 45% of active companies having a female or minority CEO or founder. Arboretum Ventures focuses on sectors such as medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.

The firm emphasizes investing in under-ventured geographies and sectors, building deep relationships with entrepreneurs, executives, and investment partners across the healthcare industry. Notable portfolio companies include NeuMoDx, which was acquired by QIAGEN in September 2020.